Tyneside health tech firm QuantuMDx has sealed a significant deal with an Italian firm to distribute its portable Covid, flu and respiratory disease testing system in the UK and France.
Earlier this year, the Newcastle company - which last year secured £15m venture capital investment - revealed its latest Q-POC respiratory panel test which can also detect Covid and other infectious diseases. The team had developed a new test to include the most up to date information on sequences of SARS-CoV-2, Flu A and Flu B & RSV viruses. Respiratory panel tests detect pathogens in the lungs, nose and throat.
Now the diagnostic specialist has announced an agreement which will see Florence-based Menarini market, sell and service Q-POC, QuantuMDx’s SARS- CoV-2 assay and its new test which the company launched in June. The firm said the deal, agreed for an undisclosed value, marks a significant commercial step for QuantuMDx. It said it will ramp up commercial sales of the platform with the mission to limit the fast spread of Covid and other respiratory diseases.
